SpectroCor is rated 3 out of 5 in the category making open-heart surgery safer. Read and write reviews about SpectroCor. Worldwide well over 1 million patients are facing open heart surgery every year. Annually up to 20% of open heart surgery patients suffer from low cardiac output syndrome as a complication. Hapekas Medical will offer a novel sensor in open heart surgery in order to increase the chance of patient to have both longer and better quality of life after arduous and demanding operation. Surgeons benefit through more carefree operation and better results. Society as whole is expected to benefit through lower demand for intensive care, fewer readmissions and therefore expenses after open heart surgery operation.
Company size
1-10 employees
Headquarters
Espoo, Southern Finland